A validation of cognitive biomarkers for the early identification of cognitive enhancing agents in schizotypy: a three-centre double-blind placebo-controlled study. European Neuropsychopharmacology, Jul;22(7):469-81.

Koychev, I., McMullen, K., Lees, J., Dadhiwala, R., Grayson, L., Perry, C., Schmechtig, A., Walters, J., Craig, K.J., Dawson, G.R., Dourish, C.T., Ettinger, U., Wilkinson, L., Williams, S.C.R., Deakin, J.F.W. and Barkus, E. (2011).